HOB Biotech GroupLtd Bilan de santé
Santé financière contrôle des critères 6/6
HOB Biotech GroupLtd has a total shareholder equity of CN¥806.0M and total debt of CN¥105.1M, which brings its debt-to-equity ratio to 13%. Its total assets and total liabilities are CN¥1.0B and CN¥196.8M respectively. HOB Biotech GroupLtd's EBIT is CN¥41.6M making its interest coverage ratio 35.5. It has cash and short-term investments of CN¥105.1M.
Informations clés
13.0%
Ratio d'endettement
CN¥105.05m
Dette
| Ratio de couverture des intérêts | 35.5x |
| Argent liquide | CN¥105.13m |
| Fonds propres | CN¥806.03m |
| Total du passif | CN¥196.80m |
| Total des actifs | CN¥1.00b |
Mises à jour récentes de la santé financière
Pas de mise à jour
Recent updates
Earnings Not Telling The Story For HOB Biotech Group Corp.,Ltd (SHSE:688656) After Shares Rise 43%
Oct 08
Subdued Growth No Barrier To HOB Biotech Group Corp.,Ltd's (SHSE:688656) Price
Jul 04HOB Biotech GroupLtd's (SHSE:688656) Earnings Are Weaker Than They Seem
May 06Earnings Not Telling The Story For HOB Biotech Group Corp.,Ltd (SHSE:688656) After Shares Rise 25%
Mar 08Analyse de la situation financière
Passif à court terme: 688656's short term assets (CN¥282.5M) exceed its short term liabilities (CN¥184.0M).
Passif à long terme: 688656's short term assets (CN¥282.5M) exceed its long term liabilities (CN¥12.8M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 688656 has more cash than its total debt.
Réduire la dette: 688656's debt to equity ratio has reduced from 29% to 13% over the past 5 years.
Couverture de la dette: 688656's debt is well covered by operating cash flow (102.3%).
Couverture des intérêts: 688656's interest payments on its debt are well covered by EBIT (35.5x coverage).